Iatrogenic melanoma. Comment on: Melanoma epidemic: A midsummer night's dream?

British Journal of Dermatology

Volumn 162, Issue 2, 2010, Pages 457-458

  Van Der Rhee, J I ^a   Mooi, W J ^b   Kukutsch, N A ^a   De Snoo, F A ^a   Bergman, W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CDKN2A; Incidence; Melanoma; Overdiagnosis; Stage

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER SUSCEPTIBILITY; CARCINOMA IN SITU; DIAGNOSTIC ERROR; EPIDEMIC; GENE MUTATION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; IATROGENIC DISEASE; LETTER; MELANOMA; PRIORITY JOURNAL;

DISEASE PROGRESSION; EARLY DETECTION OF CANCER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MELANOMA; NEOPLASM INVASIVENESS; PEDIGREE; SKIN NEOPLASMS;

EID: 74349087554     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09556.x     Document Type: Letter

References (6)

1. Levell NJ, Beattie CC, Shuster S, Greenberg DC. Melanoma epidemic: a midsummer night's dream? Br J Dermatol 2009 161 : 630 634.
2. Swerlick RA, Chen S. The melanoma epidemic. Is increased surveillance the solution or the problem? Arch Dermatol 1996 132 : 881 884.
3. A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel. J Clin Pathol 1997 50 : 202 205.
4. Brochez L, Verhaeghe E, Grosshans E et al. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 2002 196 : 459 466.
5. Gruis NA, van der Velden PA, Sandkuijl LA et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 1995 10 : 351 353.
6. Kefford R, Bishop JN, Tucker M et al. Genetic testing for melanoma. Lancet Oncol 2002 3 : 653 654.